17 May 2023 School of Successful Lipidologist was held in Novosibirsk.
The event became a discussion platform for discussing modern approaches to the correction of lipid metabolism disorders, as well as innovation, available to patients.
Academician RAN, Doctor of Medical Sciences, Professor M.I. The voivode presented the modern clinical recommendations and the experience of the FRC FTM in prescribing the innovative drug Inklisiran (Sibrava). Chief Freelance Specialist for Therapy and General Practice of the Ministry of Health Novosibirsk areas, cardiologist, PhD. Dunicheva O.V. in her report, she reflected the results of the work of the cardiological service and identified the goals of working with chronic cardiological diseases as a key focus for the coming years. President of the National Society for the Study of Atherosclerosis, MD, professor Ezhov M.V. introduced Inklisiran and answered questions from the audience, including the most "sharp". Chief endocrinologist of the Ministry of Health of the Novosibirsk Region, PhD. Shabelnikova O.Yu. and Head of the Neurological Department of the FRC FTM Clinic, PhD. Khrushcheva N.A.. substantiated the relevance of attention to patients with dyslipidemia from the standpoint of an endocrinologist and a neurologist, and emphasized the need for timely intensification of therapy, including active use of 3rd line drugs. The latest report was presented by the chief physician of the FRC FTM Clinic, PhD. Shipunov M.V.. about the possibilities of access to such drugs and work with them under the CHI program. The session of clinical discussions moderated by Dr. med., Professor of the Russian Academy of Sciences Artemenko S.N., including a discussion of various clinical situations and the possibility of using Inclisiran in patients with various forms of dyslipidemia, taking into account the comorbidity of their diseases.
The School of a Successful Lipidologist Caused Heated Discussions in an Unofficial Format, which continued for more than an hour after its completion.